To evaluate the clinical significane of changes in F PSA/PSA ratio and the annual changing rate of PSA concentration in prostatic cancer patients with PSA between 4 to 10μg/L, we determined the PSA and F PSA by ELISA in different periods of time.

Relationship between transition zone volume and preoperative-to-postoperative change in serum prostate-specific antigen in patients with benign prostate hyperplasia;

Objective Objective To explore the clinical significance of detecting free prostate-specific antigen(fPSA) and total prostate-specific antigen(TPSA) ratio(f/T) and prostate-specific antigen density (PSAD) for diagnosis of prostate cancer with TPSA in diagnostic gray zone(4 to 10 ng/ml).

AIM To construct a fluorescence resonance energy transfer (FRET)-based biosensor for detecting the enzymatically active prostate-specific antigen (PSA).

The clinical significance of the proportion of free PSA to total PSA in differential diagnosis of prostate cancer;

Significance of serum PSA,F-PSA/T-PSA ratio in diagnosis of prostate cancer

Objective:To evaluate the influence of clinical procedures on serum PSA and FPSA concentration.

Detection of prostate stem cell antigen and serum prostate specific antigen of patients with prostatic cancer;

Inhibition of the expression of prostate specific antigen by curcumin;

Bone marrow prostate specific antigen in diagnosis of prostatic cancer bone metastasis;

Objective: To investigate the expression of prostate cancer antigen-1 (PCA-1) in different prostate tissues and analyze its correlation with the clinical parameters of prostate cancer (PCa).